Evidence map›Paper›PMID 35894597›Full record

ArticlemSystems2022

Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.

Salla Sariola, Andrea Butcher, Jose A Cañada, Mariette Aïkpé, Adélaïde Compaore

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Salla SariolaDepartment of Sociology, University of Helsinkigrid.7737.4, Helsinki, Finland.ORCID 0000-0003-3401-7727
Andrea ButcherDepartment of Sociology, University of Helsinkigrid.7737.4, Helsinki, Finland.
Jose A CañadaDepartment of Sociology, Philosophy and Anthropology, University of Exeter, Exeter, United Kingdom.
Mariette AïkpéLaboratory of Applied Medical Anthropology, University of Abomey-Calavi, Abomey-Calavi, Benin.
Adélaïde CompaoreClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
University of Helsinki · FIInstitut de Recherche en Sciences de la Santé · BFUniversité d'Abomey-Calavi · BJUniversity of Exeter · GB

Funding

Wellcome Trust 222863
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global concern that is geographically unevenly distributed, with low- and middle-income countries and African countries suffering in particular. The World Health Organization (WHO) Global Action Plan (GAP) for antimicrobial resistance identified five key objectives that aim to ensure the continued treatment and prevention of infectious diseases with the use of antibiotics. Countries signatory to the WHO GAP are expected to develop their own national action plans (NAPs) based on the global model. How low-income countries are able to achieve the GAP objectives is not well understood. This paper analyzes the progress of two West African countries in achieving the GAP targets, Benin and Burkina Faso, countries among the lowest bracket in the World Development Index. We present qualitative data from interviews and focus group discussions with local policy-makers, nurses, doctors, animal breeders, veterinarians, and laboratory researchers, supported by participant observations and surveys within rural communities. The analysis is organized according to the five WHO GAP objectives to show the countries' challenges in fulfilling them. The analysis shows that there are shortcomings in all of the WHO GAP areas in the two countries, making it a compounded and multifactorial problem-a stacking of lacks. In such contexts, calibrating a society toward AMR resilience/prevention requires overall development and attention to interdependencies. Active local research and policy communities with international, sustained financial support are essential for achieving the targets.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialAnimalsBeninBurkina FasoHealth PolicyHumansAnti-Bacterial Agentsantimicrobial resistanceBeninBurkina Fasoinequalitylow-income countriesqualitative researchWest Africa

Identifiers

PMID35894597
PMCPMC9426606
OpenAlexW4288067260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.